Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
about
Emerging targets and novel approaches to Ebola virus prophylaxis and treatmentHost-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing AntibodiesA general strategy to endow natural fusion-protein-derived peptides with potent antiviral activityAn update on the use of antibodies against the filoviruses.Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infectionChemical and Structural Aspects of Ebola Virus Entry Inhibitors.Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus.Filovirus entry into cells - new insights.Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry InhibitorsStructural and Functional Studies on the Marburg Virus GP2 Fusion LoopPotential vaccines and post-exposure treatments for filovirus infections.Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41Development of novel entry inhibitors targeting emerging viruses.Role of electrostatic repulsion in controlling pH-dependent conformational changes of viral fusion proteinsConformational properties of peptides corresponding to the ebolavirus GP2 membrane-proximal external region in the presence of micelle-forming surfactants and lipids.C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinkingHost cell factors in filovirus entry: novel players, new insightsPeptides as the next generation of anti-infectives.Cholesterol-conjugated peptide antivirals: a path to a rapid response to emerging viral diseases.Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: stability and pH effects.Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors.Mechanisms of Filovirus Entry.Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets.Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin.Ebolavirus: a brief review of novel therapeutic targets.General Staining and Segmentation Procedures for High Content Imaging and Analysis.Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs.An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications.Candidate medical countermeasures targeting Ebola virus cell entry
P2860
Q24597625-56AC0A0B-2C62-4465-A566-1B78EE358C9EQ27704173-635FFB4E-8CF6-4064-AC23-9FCD0B4257D7Q28729918-36B80ED3-3EF1-49A6-A4B0-F37CAB4952EFQ34657170-21A4CE72-F78E-4E9F-8FDB-2790F95A1CB2Q35061450-D74D275B-EFBB-49C9-8EDC-A73003CB164CQ35589926-AE18372A-65CC-4D94-9E49-35EBD8DAAF5AQ35604856-C28F5002-03FE-4357-98BA-62276A1043E7Q35878069-F871D35D-E9D7-44AA-B172-75404BF2BD93Q36012840-AEDA40CD-FFB2-4000-A0ED-5C7072A9C0B7Q36043176-F62F0A97-6B4E-4EB7-9E7C-84CBE180CF9FQ36404178-71FBCD18-34D2-4B35-A2A7-53A5E7C0C552Q36643050-7FF0E7A0-9178-4047-BAD1-C70825E76BD4Q36655280-B52A533A-47F7-4F9D-96CA-FE9BF1435DD9Q36983676-777C7179-1D47-4C04-843C-01E05274FFECQ37170473-76CBBA7D-2361-457E-9B30-AEE692233CB1Q37294380-8D55DB44-2D12-4442-9E5D-968A7429A6CCQ38076136-705B8B04-8565-41BD-9020-4072C0908CB8Q38086871-48675456-F791-43C5-AA63-6CAE22B474C9Q38261556-041C3E2B-A3BC-4BD1-A15B-F51AE184BCDCQ38666508-5B34248D-8CFD-487F-9924-AF9B6CB8F598Q39141291-D3196CBE-DA67-40DE-A268-39AD2EA40F0EQ40164611-7946A101-C304-45D9-A3A3-80E6AB43137DQ40188132-B9C3CB76-FC5F-486B-818D-712D6AF38F87Q41041346-A48F7AD7-2848-45C0-A893-1898273F98BDQ44092356-54FFF800-9C39-48A4-B4C7-D718F63F7046Q47589549-1562B4B6-3FD7-41FC-8C39-EFB24CFB0DACQ52724948-A247DFB0-7910-466C-A952-26B32191B816Q55237287-914ACB9C-8270-4F82-8E0D-7226FAF7C877Q56763004-6CCBD931-A8FD-4FD5-8B9B-46A9620B5EFD
P2860
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
@ast
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
@en
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
@nl
type
label
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
@ast
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
@en
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
@nl
prefLabel
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
@ast
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
@en
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
@nl
P2093
P2860
P50
P356
P1476
Inhibition of Ebola virus entry by a C-peptide targeted to endosomes.
@en
P2093
Chelsea D Higgins
Emily Happy Miller
Jonathan R Lai
Kartik Chandran
Xiaoli Chi
P2860
P304
15854-15861
P356
10.1074/JBC.M110.207084
P407
P577
2011-03-16T00:00:00Z